Susan L. Mills

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 349 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Alzheimer's Disease +9

The spectral composition of evening light and individual differences in the suppression of melatonin and delay of sleep in humans

Nayantara Santhi, Helen Thorne, Daan R. van der Veen et al. · Journal of Pineal Research · 2011 · 222 citations

Sleep Disorders, Sleep Health, Individual Differences +25

Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials

Stacie Weninger, María C. Carrillo, Billy Dunn et al. · Alzheimer s & Dementia · 2016 · 34 citations · Full text

Neurodegenerative Diseases, Preventive Medicine, Alzheimer's Disease +12

Toward consensus on self-management support: the international chronic condition self-management support framework

Susan L. Mills, Teresa J. Brady, Janaki Jayanthan et al. · Health Promotion International · 2016 · 32 citations · Full text

Family Medicine, Self-management, Toward Consensus +25

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Randall J. Bateman, Yan Li, Eric McDade et al. · The Lancet Neurology · 2025 · 26 citations

Neurodegenerative Diseases, Geriatric Neurology, Alzheimer's Disease +12